Sermion tablets p/o 30mg №15×2

Name:
Sermion tabl p/o 30mg in a blister. in pack. No. 15×2 Main active ingredient Nicergoline Release formtablets Composition Active substance: nicergoline. One coated tablet contains 5, 10 or 30 mg of nicergoline. Other excipients: Tablet core: calcium hydrogen phosphate dihydrate (E341), microcrystalline cellulose (E460), magnesium stearate (E470), sodium carboxymethylcellulose (E466). Tablet shell (for tablets 5 mg and 10 mg): sucrose, talc (E553), acacia resin (E414), sandarac resin, magnesium carbonate (E504), titanium dioxide (E171), rosin, carnauba wax (E903), sunset yellow (E110, for 5mg tablets); Tablet shell (for 30 mg tablets): hydroxypropyl methylcellulose (E464), titanium dioxide (E171), polyethylene glycol 6000 (E1521), iron oxide yellow (E172), silicone.
Description:
Sermion, 5 mg – round, convex film-coated tablets, orange. Sermion, 10 mg – round, convex film-coated tablets, white. Sermion, 30 mg – round, biconvex film-coated tablets, yellow. Coated tablets 5 mg; 15 tablets in a blister (PVC / PVDC – aluminum foil), 2 blisters and instructions for use in a cardboard box. Coated tablets 10 mg; 25 tablets in a blister (PVC / PVDC – aluminum foil), 2 blisters and instructions for use in a cardboard box. Film-coated tablets 30 mg; 15 tablets in a blister (PVC / PVDC – aluminum foil), 2 blisters and instructions for use in a cardboard box. Dosage 5 mg; 10 mg; 30 mg; Indications for use The active substance contained in Sermion is a semi-synthetic derivative of the ergot alkaloid, which has a beneficial effect on impaired brain metabolism in the elderly. The active substance (nicergoline) connects to certain binding sites of various messenger substances produced in the human body and affecting the transmission of impulses between nerve cells. An imbalance in the content of these messenger substances leads to the development of disorders. In this way, Sermion promotes recovery processes in the brain in deficient conditions. Sermion is used as an aid in the treatment of symptoms of brain dysfunction caused by the aging process and impaired cerebral circulation. These disorders can manifest as follows: attention deficit disorders and memory impairment; concentration disorders; decrease in motivation; non-compliance with personal hygiene; fatigue or dizziness; decrease or absence of social seclusion, self-isolation). Before starting treatment with Sermion, your doctor will make sure that these symptoms are not a manifestation of another disease (therapeutic, psychiatric or neurological profile) and do not require specific treatment. Contraindications if you are hypersensitive (allergic) to the active substance – nicergoline, other derivatives of ergot alkaloids or any other component that is part of Sermion (listed in the Composition section); if you have recently had a myocardial infarction; with acute bleeding; at risk or tendency to collapse; with a rare heartbeat; in case of dizziness and fainting that occur in certain circumstances, for example, when standing up quickly Use during pregnancy and lactation If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using the medicine. Given the indications for use (see section “What is Sermion and when is this drug used”), the use of this drug in pregnant women and women who are breastfeeding is unlikely and is not intended. Sermion should not be used during pregnancy and during breastfeeding. Method of application and doses In all cases, you should strictly follow the instructions of the doctor. If you have any doubts about the use of the drug, consult your doctor or pharmacist. As a rule, the dose of the drug is 1-2 tablets per day. Accordingly, one tablet during breakfast and, if necessary, the next tablet is taken at dinner. If your doctor has prescribed Sermion one tablet 30 mg per day (for example, if you have impaired kidney function), then it is best to take it with breakfast. Tablets should be taken with meals, without chewing, with a small amount of water. Due to the fact that positive dynamics is usually observed after 4-6 weeks from the start of treatment, it is recommended to take the drug for a long period of time. At certain intervals (but not less than every 6 months), the doctor will evaluate the advisability of continuing treatment with Sermion. Children and adolescents under 18 years of age Sermion is not intended for use in children and adolescents under 18 years of age. Patients with impaired renal function Your doctor will prescribe the dose you need. If your kidney function is severely impaired, your doctor may prescribe the drug at a lower dose. The effect of treatment appears gradually. Since treatment is usually carried out over a long period of time, the attending physician will determine at appropriate intervals whether to continue treatment. In this case, you should immediately consult a doctor. Special treatment is usually not required, and in most cases it is enough to take a horizontal position for a few minutes. In exceptional cases, the doctor will take the necessary measures. If you forget to take a drug Do not take a double dose of Sermion to make up for the missed dose and continue taking the drug as directed by your doctor. If you stop taking Sermion Do not stop taking Sermion abruptly without first talking to your doctor. If adverse reactions occur, your doctor will discuss with you possible measures, as well as the possibility of prescribing other medicines for their treatment. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. Side effects As with other medicines, Sermion can sometimes cause side effects, although not everyone gets them. Common (may affect up to 1 in 10 people) Complaints of abdominal pain. Uncommon (may affect up to 1 in 100 people) Hyperactivity, confusion, insomnia, drowsiness, dizziness and weakness, headaches, low blood pressure, skin redness, constipation, diarrhea, nausea, itching, increased blood uric acid. Not known: frequency cannot be estimated from the available data Hot flashes and fever, skin rash, painful growth of connective tissue (fibrosis), nasal congestion. Reporting side effects If you notice any side effects, including those not listed in this leaflet, please tell your doctor or pharmacist. By providing information about adverse events, you help to collect information about the safety of this drug. Interactions with other drugs Tell your doctor or pharmacist if you are currently taking, have recently taken or may take any other medicines. Taking two or more drugs can cause drug interactions even if the drugs are taken at different times. The effects and side effects of these drugs may be increased or decreased. Your healthcare provider will check which medicines you are taking and adjust your intake if necessary. Sermion can enhance the effect of drugs used to reduce high blood pressure (including the so-called “beta-blockers”). The vasoconstrictive effect of certain drugs on smooth muscles (drugs with a symptomatic effect) may be weakened by Sermion. Sermion can lengthen the clotting time, increased under the influence of acetylsalicylic acid or certain anticoagulants. Care must be taken while using Sermion with drugs that affect the metabolism and excretion of uric acid (due to the risk of gout). Influence of food, drinks and alcohol During treatment with Sermion (as with any other medicines), alcohol should not be consumed, as the effect may be unpredictable. Precautions: Talk to your doctor or pharmacist before using Sermion. Sermion should be taken with caution: with a mild to moderate decrease in heart rate; if you suffer from a bleeding disorder or are taking drugs that inhibit coagulation. In some cases, your doctor may do blood tests more often than usual; if you have high levels of uric acid in your blood, or you are taking or have previously taken medicines to treat gout. simultaneous treatment with sympathomimetics (alpha or beta). When using some derivatives of ergot alkaloids, cases of fibrosis of the lungs, heart, heart valves and retroperitoneal space were observed. After taking some ergot alkaloids and their derivatives, the following symptoms were observed: nausea, vomiting, diarrhea, abdominal pain and peripheral vasospasm. Storage conditions Store the drug at a temperature not exceeding 25°C. Keep the drug out of the reach of children. Do not use the drug after the expiration date indicated on the carton or on the blister after the word “EXP”. The expiry date is the last day of the specified month. Medicines should not be thrown into the sewer or with household waste. For instructions on handling unused medicines, contact your pharmacist. These measures will help protect the environment. Buy Sermion tablets p/o 30mg №15×2